Elacestrant Dihydrochloride

3 trials 3 recruiting

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

3 Recruiting

0 Completed trials

3 Sponsors

3 Countries

Phase II

Phase II: 3

Indications tested

Breast cancer metastatic 1

Sponsors using this IMP

GBG Forschungs GmbH 1 Institut Gustave Roussy 1 Solti Group 1

All trials

3 total

A short-term preoperative, window-of-opportunity study, evaluating activity and safety of Elacestrant monotherapy as compared to Elacestrant… Recruiting

2024-520051-24-00 Phase II 1 country Institut Gustave Roussy
Phase II study evaluating the addition of elacestrant, an oral selective estrogen receptor degrader (SERD), to standard-of-care olaparib in … Recruiting

2023-504925-38-00 Phase II 1 country GBG Forschungs GmbH
Phase II, multicenter, randomized, open-label study of premenopausal women with luminal breast cancer investigating the effect of elacestran… Recruiting

2023-503373-37-01 Phase II 1 country Solti Group

Showing 1–3 of 3 trials

← All drugs A–Z